Molecule intelOpportunity: Moderate0

Serratiopeptidase

21 brands · 13 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
37
Market saturation
34
Price room
100
Regulatory risk
50
21
brands
13
companies
Rs 243.7
median price
14
price points
118.75x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 4.16
MedianRs 243.7
Most expensiveRs 494
Spread118.75×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 118.75x across 14 trusted points (Rs 4.16-494.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 5 live products for Serratiopeptidase — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2026-06-02
32. Rapid Alert – SPURIOUS / FALSIFIED DANZEN DS TABLETS

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(66) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

13 canonical companies and 21 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 118.75x across 14 trusted points (Rs 4.16-494.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-06-02 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.